GLP-1
Clinical trials for GLP-1 explained in plain language.
Never miss a new study
Get alerted when new GLP-1 trials appear
Sign up with your email to follow new studies for GLP-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Multivitamins may protect against nutrient loss in GLP-1 users
Disease control ENROLLING_BY_INVITATIONThis study looks at whether taking a daily multivitamin can prevent vitamin and mineral deficiencies in people using GLP-1 drugs (like tirzepatide) for weight loss. About 246 adults with obesity who have been on a stable GLP-1 dose for at least 3 months will be randomly assigned …
Matched conditions: GLP-1
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Diabetes drug eye risk under microscope
Knowledge-focused OngoingThis study looks at how newer diabetes medications (SGLT2 inhibitors and GLP-1 receptor agonists) affect the eyes of people with type 2 diabetes. Researchers will monitor 40 adults who take metformin and are starting these newer drugs. The goal is to see if these drugs cause any …
Matched conditions: GLP-1
Sponsor: University of Athens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC